| Application no. and date | 08166780.0 (espacenet) (Federated) (European Patent Register), 20030527 | | Patent/reg. no. and date | DK/EP 2020243, 20180815 | | Publication date | 20090204 | | Priority no. and date | DE 10223828, 20020528, EP 02011830, 20020528, DE 10311613, 20030314 | | EP pub. no. and date |
EP 2020243 20090204 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AstraZeneca TAK1105-EP-ETD | | Inventor | LINDER, Rudolf, Lindauerstrasse 40
78464 Konstanz, DE,
Bolle, Christina, Dornacherstrasse 290
4053 Basel, CH | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 47/06 (2006.01) , A61K 47/32 (2006.01) , A61K 47/44 (2017.01) | | Title | Farmaceutisk præparat, der kan påføres topisk | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
